Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;478(1):59-72.
doi: 10.1007/s00428-021-03031-7. Epub 2021 Jan 21.

Pleural mesothelioma classification update

Mary Beth Beasley  1 , Francoise Galateau-Salle  2 , Sanja Dacic  3
Affiliations
Review

Pleural mesothelioma classification update

Mary Beth Beasley et al. Virchows Arch. 2021 Jan.

Abstract

The 2015 WHO classification of pleural mesotheliomas includes three major histologic subtypes-epithelioid, sarcomatoid, and biphasic. Recent genomic data has supported the need for a more granular and clinically valid classification beyond the three current subtypes. Because of tumor rarity and overlapping histologic features with other tumor types, diagnostic immunohistochemical work up is essential component in establishing the final diagnosis of mesothelioma. The use of BAP1 and CDKN2A/MTAP improves the diagnostic sensitivity of effusion specimens and are valuable in establishing the diagnosis of epithelioid mesothelioma. The major change in the forthcoming WHO classification is the inclusion of mesothelioma in situ as a diagnostic category. In this review, we discuss recently proposed changes in the histologic classification of pleural mesothelioma, differential diagnosis, and importance of ancillary diagnostic studies.

Keywords: Histologic classification; Mesothelioma; Pleura.

PubMed Disclaimer

References

    1. Ahadi MS, Gill AJ (2019) SMARCA4 loss is very rare in thoracic mesothelioma. Am J Surg Pathol 43:1154–1155. https://doi.org/10.1097/PAS.0000000000001262 - DOI - PubMed
    1. Alchami FS, Attanoos RL, Bamber AR (2017) Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma. J Clin Pathol 70:179–182. https://doi.org/10.1136/jclinpath-2016-203993 - DOI - PubMed
    1. Andrici J, Sheen A, Sioson L, Wardell K, Clarkson A, Watson N, Ahadi MS, Farzin M, Toon CW, Gill AJ (2015) Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology. Mod Pathol 28:1360–1368. https://doi.org/10.1038/modpathol.2015.87 - DOI - PubMed - PMC
    1. Arif Q, Husain AN (2015) Malignant mesothelioma diagnosis. Arch Pathol Lab Med 139:978–980. https://doi.org/10.5858/arpa.2013-0381-RA - DOI - PubMed
    1. Attanoos RL, Pugh MR (2018) The diagnosis of pleural tumors other than mesothelioma. Arch Pathol Lab Med 142:902–913. https://doi.org/10.5858/arpa.2017-0537-RA - DOI - PubMed

MeSH terms

LinkOut - more resources